Her primary areas of study are Virology, Immunology, Virus, Lentivirus and Antibody. Her study in Virology is interdisciplinary in nature, drawing from both Molecular mimicry, Immunoglobulin heavy chain and Somatic hypermutation. In the field of Immunology, her study on Pathogenesis, Mucous membrane and Interleukin 21 overlaps with subjects such as Population.
Arlene Hurley has researched Virus in several fields, including RNA and Combination therapy. Her study in the field of Epitope, Epitope mapping and Gp41 also crosses realms of Binding site. Her Viral load study incorporates themes from Virus latency, Lamivudine, Nelfinavir and Zidovudine.
The scientist’s investigation covers issues in Virology, Immunology, Virus, Antibody and Immune system. Her work deals with themes such as RNA, Peripheral blood mononuclear cell and Severe acute respiratory syndrome coronavirus 2, which intersect with Virology. Her Virus research incorporates themes from Cytotoxic T cell, CTL* and Nelfinavir.
Her work in Antibody tackles topics such as Coronavirus which are related to areas like Polyclonal antibodies and Avidity. Her research in Immune system tackles topics such as Immunopathology which are related to areas like Humoral immunity. Her Viral load study combines topics from a wide range of disciplines, such as Virus latency and Protease inhibitor.
Antibody, Virology, Epitope, Antigen and Severe acute respiratory syndrome coronavirus 2 are her primary areas of study. Her research integrates issues of Emergency Use Authorization and Saliva in her study of Virology. Her Epitope research is multidisciplinary, incorporating perspectives in Neutralizing antibody and Neutralization.
Her Antigen study is related to the wider topic of Immunology. Many of her studies on Immunology involve topics that are commonly interrelated, such as Cell division. Her Severe acute respiratory syndrome coronavirus 2 course of study focuses on Spike Protein and Ic50 values.
Her main research concerns Antibody, Epitope, Virology, Spike Protein and Viral entry. Her Antibody research includes elements of Asymptomatic, Ic50 values and Coronavirus. Her Asymptomatic study combines topics in areas such as Somatic hypermutation, Virus, Immunology, Antigen and Immunity.
Her research on Virus frequently connects to adjacent areas such as Immunofluorescence. Her studies in Coronavirus integrate themes in fields like Neutralizing antibody, Epitope mapping, Avidity and Polyclonal antibodies. Her Spike Protein research incorporates elements of Antibody response and Severe acute respiratory syndrome coronavirus 2.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Decay characteristics of HIV-1-infected compartments during combination therapy
Alan S. Perelson;Paulina Essunger;Yunzhen Cao;Mika Vesanen.
Nature (1997)
Convergent antibody responses to SARS-CoV-2 in convalescent individuals.
Davide F. Robbiani;Davide F. Robbiani;Christian Gaebler;Frauke Muecksch;Julio C.C. Lorenzi.
Nature (2020)
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA.
G. S. Ogg;Xia Jin;S. Bonhoeffer;P. R. Dunbar.
Science (1998)
Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.
Saurabh Mehandru;Michael A. Poles;Michael A. Poles;Klara Tenner-Racz;Amir Horowitz;Amir Horowitz.
Journal of Experimental Medicine (2004)
Sequence and structural convergence of broad and potent HIV antibodies that mimic CD4 binding.
Johannes F. Scheid;Hugo Mouquet;Beatrix Ueberheide;Ron Diskin.
Science (2011)
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants.
Zijun Wang;Fabian Schmidt;Yiska Weisblum;Frauke Muecksch.
Nature (2021)
Evolution of antibody immunity to SARS-CoV-2.
Christian Gaebler;Zijun Wang;Julio C. C. Lorenzi;Frauke Muecksch.
Nature (2021)
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Johannes F. Scheid;Hugo Mouquet;Niklas Feldhahn;Michael S. Seaman.
Nature (2009)
HIV-1 drug resistance in newly infected individuals.
Daniel Boden;Arlene Hurley;Linqi Zhang;Yunzhen Cao.
JAMA (1999)
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.
Christopher O. Barnes;Anthony P. West;Kathryn E. Huey-Tubman;Magnus A.G. Hoffmann.
Cell (2020)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Rockefeller University
Columbia University
Rockefeller University
Rockefeller University
Rockefeller University
California Institute of Technology
Rockefeller University
Los Alamos National Laboratory
Universita della Svizzera Italiana
Rockefeller University
Carnegie Mellon University
Australian National University
University of Western Ontario
University of Córdoba
University of Illinois at Urbana-Champaign
University of Manchester
University of Melbourne
Lamont-Doherty Earth Observatory
Ames Research Center
Ruhr University Bochum
Harvard University
Ludwig-Maximilians-Universität München
National Institutes of Health
Universität Hamburg
Columbia University
McMaster University